Current biochemical studies of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) suggest a new therapeutic approach: Lin Hz, Yang SQ, Chuckaree C, et al., Metformin’s Reverses Fatty Liver Disease in Obese Leptin-Deficient Mice, Nature Medicine 2000;6(8):998–1003

✍ Scribed by Perry Hookman; Jamie S Barkin

• Book ID: 119393886
• Publisher: Nature Publishing Group
• Year: 2003
• Tongue: English
• Weight: 60 KB
• Volume: 98
• Category: Article
• ISSN: 0002-9270
• DOI: 10.1016/s0002-9270(02)05998-1